# Methylene Blue for the Prevention of Hypotension During Hemodialysis

> **NCT05092165** · PHASE2 · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 261 (actual)

## Conditions studied

- Acute Kidney Injury
- Shock
- Intradialytic Hypotension
- Intradialytic Hypertension in Hemodialysis Patients

## Interventions

- **DRUG:** Methylene Blue
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT05092165
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-21
- **Primary completion:** 2025-12-16
- **Final completion:** 2025-12-16
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05092165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05092165, "Methylene Blue for the Prevention of Hypotension During Hemodialysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05092165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*